Skip to main content
. Author manuscript; available in PMC: 2015 Jan 1.
Published in final edited form as: J Allergy Clin Immunol. 2014 Jan;133(1):27–33. doi: 10.1016/j.jaci.2013.10.026

Table 2.

BARD Study ICS Dosing in Children aged 5–11 and Adults/Adolescents aged ≥12Years

Children Adolescents/Adults
Run In Dose 1 × ICS 50 mcg fluticasone propionate BID 1 × ICS 100 mcg fluticasone propionate BID
Phase A 2 × ICS 100 mcg fluticasone propionate BID 2.5 × ICS 250 mcg fluticasone propionate BID
Phase B 5 × ICS 250 mcg fluticasone propionate BID 5 × ICS 500 mcg fluticasone propionate BID
Phase C 2 × ICS + LABA 100 mcg fluticasone propionate & 50 mcg salmeterol BID 1 × ICS + LABA 100 mcg fluticasone propionate & 50 mcg salmeterol BID
Phase D 5 × ICS + LABA 250 mcg fluticasone propionate & 50 mcg salmeterol BID 2.5 × ICS + LABA 250 mcg fluticasone propionate & 50 mcg salmeterol BID